216 related articles for article (PubMed ID: 26846710)
1. Evaluation of BP-ONJ in osteopenic and healthy sheep: comparing ZTE-MRI with µCT.
Voss P; Ludwig U; Poxleitner P; Bergmaier V; El-Shafi N; von Elverfeldt D; Stadelmann V; Hövener JB; Flügge T
Dentomaxillofac Radiol; 2016; 45(4):20150250. PubMed ID: 26846710
[TBL] [Abstract][Full Text] [Related]
2. Zoledronate induces bisphosphonate-related osteonecrosis of the jaw in osteopenic sheep.
Voss PJ; Stoddart MJ; Bernstein A; Schmelzeisen R; Nelson K; Stadelmann V; Ziebart T; Poxleitner PJ
Clin Oral Investig; 2016 Jan; 20(1):31-8. PubMed ID: 25843053
[TBL] [Abstract][Full Text] [Related]
3. Lansoprazole and zoledronate delays hard tissue healing of tooth extraction sockets in dexamethasone-treated mice.
Yoshioka R; Mine Y; Kaku M; Nikawa H; Murayama T
Biomed Pharmacother; 2022 Jun; 150():112991. PubMed ID: 35462336
[TBL] [Abstract][Full Text] [Related]
4. Zoledronate induces osteonecrosis of the jaw in sheep.
Voss PJ; Stoddart M; Ziebart T; Zeiter S; Nelson K; Bittermann G; Schmelzeisen R; Poxleitner P
J Craniomaxillofac Surg; 2015 Sep; 43(7):1133-8. PubMed ID: 26154396
[TBL] [Abstract][Full Text] [Related]
5. Animal model for medication-related osteonecrosis of the jaw with precedent metabolic bone disease.
Kim JW; Tatad JCI; Landayan MEA; Kim SJ; Kim MR
Bone; 2015 Dec; 81():442-448. PubMed ID: 26297440
[TBL] [Abstract][Full Text] [Related]
6. Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw.
Fleisher KE; Raad RA; Rakheja R; Gupta V; Chan KC; Friedman KP; Mourtzikos KA; Janal M; Glickman RS
J Oral Maxillofac Surg; 2014 Oct; 72(10):1957-65. PubMed ID: 25053572
[TBL] [Abstract][Full Text] [Related]
7. Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice.
Kang B; Cheong S; Chaichanasakul T; Bezouglaia O; Atti E; Dry SM; Pirih FQ; Aghaloo TL; Tetradis S
J Bone Miner Res; 2013 Jul; 28(7):1631-40. PubMed ID: 23426919
[TBL] [Abstract][Full Text] [Related]
8. Osteonecrosis of the Jaw Developed in Mice: DISEASE VARIANTS REGULATED BY γδ T CELLS IN ORAL MUCOSAL BARRIER IMMUNITY.
Park S; Kanayama K; Kaur K; Tseng HC; Banankhah S; Quje DT; Sayre JW; Jewett A; Nishimura I
J Biol Chem; 2015 Jul; 290(28):17349-66. PubMed ID: 26013832
[TBL] [Abstract][Full Text] [Related]
9. Absence of exposed bone following dental extraction in beagle dogs treated with 9 months of high-dose zoledronic acid combined with dexamethasone.
Allen MR; Chu TM; Ruggiero SL
J Oral Maxillofac Surg; 2013 Jun; 71(6):1017-26. PubMed ID: 23375897
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapeutic and antiresorptive combination therapy suppressed lymphangiogenesis and induced osteonecrosis of the jaw-like lesions in mice.
Kuroshima S; Yamashita J
Bone; 2013 Sep; 56(1):101-9. PubMed ID: 23727433
[TBL] [Abstract][Full Text] [Related]
11. Periosteal microcirculatory reactions in a zoledronate-induced osteonecrosis model of the jaw in rats.
Janovszky Á; Szabó A; Varga R; Garab D; Boros M; Mester C; Beretka N; Zombori T; Wiesmann HP; Bernhardt R; Ocsovszki I; Balázs P; Piffkó J
Clin Oral Investig; 2015 Jul; 19(6):1279-88. PubMed ID: 25352470
[TBL] [Abstract][Full Text] [Related]
12. Effect of local vs. systemic bisphosphonate delivery on dental implant fixation in a model of osteonecrosis of the jaw.
Abtahi J; Agholme F; Sandberg O; Aspenberg P
J Dent Res; 2013 Mar; 92(3):279-83. PubMed ID: 23264610
[TBL] [Abstract][Full Text] [Related]
13. Effect of anti-angiogenesis induced by chemotherapeutic monotherapy, chemotherapeutic/bisphosphonate combination therapy and anti-VEGFA mAb therapy on tooth extraction socket healing in mice.
Akita Y; Kuroshima S; Nakajima K; Hayano H; Kanai R; Sasaki M; Sawase T
J Bone Miner Metab; 2018 Sep; 36(5):547-559. PubMed ID: 29043461
[TBL] [Abstract][Full Text] [Related]
14. Development of a rat model of bisphosphonate-related osteonecrosis of the jaw (BRONJ).
Marino KL; Zakhary I; Abdelsayed RA; Carter JA; O'Neill JC; Khashaba RM; Elsalanty M; Stevens MR; Borke JL
J Oral Implantol; 2012 Sep; 38 Spec No():511-8. PubMed ID: 21905888
[TBL] [Abstract][Full Text] [Related]
15. [Bisphosphonate and osteonecrosis of the jaw.].
Taguchi A
Clin Calcium; 2017; 27(2):225-231. PubMed ID: 28123124
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonate-induced osteonecrosis of the jaw in a rat model arises first after the bone has become exposed. No primary necrosis in unexposed bone.
Abtahi J; Agholme F; Sandberg O; Aspenberg P
J Oral Pathol Med; 2012 Jul; 41(6):494-9. PubMed ID: 22268631
[TBL] [Abstract][Full Text] [Related]
17. Prevention of osteonecrosis of the jaw by mucoperiosteal coverage in a rat model.
Abtahi J; Agholme F; Aspenberg P
Int J Oral Maxillofac Surg; 2013 May; 42(5):632-6. PubMed ID: 23499148
[TBL] [Abstract][Full Text] [Related]
18. Persisting alveolar sockets-a radiologic symptom of BP-ONJ?
Groetz KA; Al-Nawas B
J Oral Maxillofac Surg; 2006 Oct; 64(10):1571-2. PubMed ID: 16982320
[No Abstract] [Full Text] [Related]
19. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
Walter C; Al-Nawas B; Grötz KA; Thomas C; Thüroff JW; Zinser V; Gamm H; Beck J; Wagner W
Eur Urol; 2008 Nov; 54(5):1066-72. PubMed ID: 18602738
[TBL] [Abstract][Full Text] [Related]
20. Rheumatoid Arthritis Exacerbates the Severity of Osteonecrosis of the Jaws (ONJ) in Mice. A Randomized, Prospective, Controlled Animal Study.
de Molon RS; Hsu C; Bezouglaia O; Dry SM; Pirih FQ; Soundia A; Cunha FQ; Cirelli JA; Aghaloo TL; Tetradis S
J Bone Miner Res; 2016 Aug; 31(8):1596-607. PubMed ID: 26950411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
